Tel-Aviv University
Tel Aviv, Israel
NCT Number: NCT01397032
Children with social anxiety will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to direct attention away from threat or a placebo control condition not designed to change attention patterns. Outcome measures will be depression and social anxiety symptoms as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews with children and their parents.
We expect to see significant reduction in social anxiety symptoms in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group.
Looking for future studies?
Notify Me7 year–18 year
All sexes
Interventional
Phase 2
Tel Aviv, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Behavioral: Attention Bias Modification Treatment (ABMT) Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.
Attention training using a computerized spatial attention task (dot-probe) not intended to alter threat-related attention patterns.
Time frame: expected average time frame of 6 weeks. Participants will be assessed before and after the administriation of the training/control protocols.
The ADIS is a semi-structured interview assessing anxiety, mood and externalizing disorders in children according to DSM-IV criteria.
Time frame: expected average time frame of 6 weeks. Participants will be assessed before and after the administriation of the training/control protocols.
The SPAI is a 26-item self and parent-report instrument designed to assess social anxiety in children and adolescents. Items assess a range of potentially anxiety-producing situations.
Tel Aviv University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06977087
Anxiety Disorders, Mental Disorders
Marburg, Germany
View Trial DetailsNCT05968651
Anxiety Disorders, Mental Disorders
Seattle, Washington, United States
View Trial DetailsNCT07129408
Agoraphobia, Alcohol Addiction
Bratislava, Slovakia
View Trial DetailsNCT02872051
Anxiety Disorders, Behavior
Copenhagen, Capital Region of Denmark, Denmark
View Trial Details